<p>BioCentury’s new in-depth conversational series launches with Scott Gottlieb as debut guest.</p>

Ep. 100 - Capital markets check in; plus Belgium’s prodigal son returns

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.